Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled, Cross-over Evaluation of Evoked Responses as Pharmacodynamic Biomarkers in Healthy Adults and Schizophrenic Patients
Conditions
Interventions
Nicotine patch
MK-4334
+2 more
Locations
2
United States
Collaborative Neuroscience Research, LLC ( Site 0002)
Long Beach, California, United States
Hassman Research Institute Marlton Site ( Site 0001)
Marlton, New Jersey, United States
Start Date
April 27, 2022
Primary Completion Date
September 23, 2022
Completion Date
November 4, 2022
Last Updated
November 29, 2024
NCT07446478
NCT05686239
NCT03745820
Lead Sponsor
Merck Sharp & Dohme LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions